Track Abbott Laboratories — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Abbott Laboratories ABT.MX · Stock Open Abbott Laboratories in new tab

1890.00 MXN
P/E
36.07
EPS
52.40
Yield
2.18%
P/B
3.78
ROE
10.58
Beta
0.58
Loading chart...
Key Metrics
P/E36.07
EPS52.40
Book Value500.61
Price to Book3.78
Debt/Equity63.21
% Insiders0.495%
Growth
Revenue Growth0.13%
Earnings Growth-0.48%
Dividend
Dividend Yield2.18%
Annual dividends42.91 MXN
Ex-Div. DateJuly 15, 2026
Payout78.96%
5y avg Yield1.87%

DCF Valuation

Tweak assumptions to recompute fair value for Abbott Laboratories (ABT.MX)
Currency: MXN
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Abbott Laboratories Logo Abbott Laboratories Analysis (ABT.MX)

United States Health Care Official Website Stock

Is Abbott Laboratories a good investment? Abbott Laboratories (ABT.MX) is currently trading at 1890.00 MXN.

In terms of valuation, the stock trades at a P/E ratio of 36.07. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Abbott Laboratories pays a dividend yield of 2.18%. With a payout ratio of 79%, the dividend appears to be under pressure.

Investor FAQ

Does Abbott Laboratories pay a dividend?

Yes, it pays an annual dividend of 42.91 MXN (2.18% yield).

What asset class is Abbott Laboratories?

Abbott Laboratories is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Exchange Ticker
NYQ (United States) ABT
SGO (Chile) ABTCL.SN
SGO (Chile) ABT.SN
GER (Germany) ABL.DE
MEX (Mexico) ABT.MX
FRA (Germany) ABL.F
VIE (Austria) ABT.VI
BUE (Argentina) ABT.BA
MIL (Italy) ABT.MI
SAO (Brazil) ABTT34.SA
STU (Germany) ABL.SG
EBS (Ireland) ABT.SW
Trades
Dividend Yield
2.18%
5y avg 1.87%
Annual Dividends
42.91MXN
Next Ex. Div Date
July 15, 2026
Payout Ratio
78.96%
Dividend History paid per year (MXN)
Historical Dividends
Year Total Dividends
2027
35.72 MXN
July 13, 2027 (estimated) 11.9061
April 13, 2027 (estimated) 11.9061
Jan. 11, 2027 (estimated) 11.9061
2026
43.20 MXN
Oct. 12, 2026 (estimated) 11.1501
July 15, 2026 10.6829
April 15, 2026 10.6829
Jan. 15, 2026 10.6829
2025
40.02 MXN
Oct. 15, 2025 10.0046
July 15, 2025 10.0046
April 15, 2025 10.0046
Jan. 15, 2025 10.0046
2024
37.31 MXN
Oct. 15, 2024 9.3264
July 15, 2024 9.3264
April 12, 2024 9.3264
Jan. 11, 2024 9.3264
2023
34.59 MXN
Oct. 12, 2023 8.6481
July 13, 2023 8.6481
April 13, 2023 8.6481
Jan. 12, 2023 8.6481
2022
31.88 MXN
Oct. 13, 2022 7.9698
July 14, 2022 7.9698
April 13, 2022 7.9698
Jan. 13, 2022 7.9698
2021
30.52 MXN
Oct. 14, 2021 7.6307
July 14, 2021 7.6307
April 14, 2021 7.6307
Jan. 14, 2021 7.6307
2020
24.42 MXN
Oct. 14, 2020 6.1045
July 14, 2020 6.1045
April 14, 2020 6.1045
Jan. 14, 2020 6.1045
2019
21.70 MXN
Oct. 11, 2019 5.4262
July 12, 2019 5.4262
April 12, 2019 5.4262
Jan. 14, 2019 5.4262
2018
18.99 MXN
Oct. 12, 2018 4.7480
July 12, 2018 4.7480
April 12, 2018 4.7480
Jan. 11, 2018 4.7480
2017
13.48 MXN
Oct. 12, 2017 4.4936
April 11, 2017 4.4936
Jan. 11, 2017 4.4936
2016
17.64 MXN
Oct. 12, 2016 4.4088
July 13, 2016 4.4088
April 13, 2016 4.4088
Jan. 13, 2016 4.4088
2015
16.28 MXN
Oct. 13, 2015 4.0697
July 13, 2015 4.0697
April 13, 2015 4.0697
Jan. 13, 2015 4.0697
2014
14.92 MXN
Oct. 10, 2014 3.7305
July 11, 2014 3.7305
April 11, 2014 3.7305
Jan. 13, 2014 3.7305
2013
9.50 MXN
Oct. 10, 2013 2.3740
July 11, 2013 2.3740
April 11, 2013 2.3740
Jan. 11, 2013 2.3740
2012
34.08 MXN
Oct. 11, 2012 8.6481
July 11, 2012 8.6481
April 11, 2012 8.6481
Jan. 11, 2012 8.1394
2011
39.34 MXN
Oct. 12, 2011 8.1394
July 13, 2011 8.1394
April 13, 2011 8.1394
Jan. 17, 2011 7.4611
Jan. 12, 2011 7.4611
2010
29.17 MXN
Oct. 13, 2010 7.4611
July 13, 2010 7.4611
April 13, 2010 7.4611
Jan. 13, 2010 6.7828
2009
58.06 MXN
Oct. 13, 2009 6.7828
July 13, 2009 6.7828
May 27, 2009 31.6062
April 13, 2009 6.7828
Jan. 13, 2009 6.1045
2008
55.43 MXN
Oct. 10, 2008 6.1045
July 11, 2008 6.1045
May 20, 2008 31.6062
April 11, 2008 6.1045
Jan. 11, 2008 5.5110
2007
93.18 MXN
Oct. 11, 2007 5.5110
July 11, 2007 5.5110
April 11, 2007 5.5110
March 8, 2007 71.6407
Jan. 10, 2007 5.0023
2006
93.42 MXN
Oct. 11, 2006 5.0023
July 12, 2006 5.0023
June 6, 2006 21.0708
April 11, 2006 5.0023
March 2, 2006 52.6770
Jan. 11, 2006 4.6632
2005
35.06 MXN
Oct. 12, 2005 4.6632
July 13, 2005 4.6632
June 8, 2005 21.0708
April 13, 2005 4.6632
Upcoming Dividends
Name Payment Date Status Amount
Abbott Laboratories Jul 15, 2026 10.68291 MXN
Abbott Laboratories Apr 15, 2026 10.68291 MXN
Abbott Laboratories Jan 15, 2026 10.68291 MXN
Abbott Laboratories Oct 15, 2025 10.00463 MXN
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion